Namodenoson

Unknown Manufacturer

Namodenoson has been used in trials studying the treatment of Chronic Hepatitis C and Hepatocellular Carcinoma.

Overview

Namodenoson has been used in trials studying the treatment of Chronic Hepatitis C and Hepatocellular Carcinoma.

Technical identifiers

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

TREATMENT OF PANCREATIC CANCER
EP 4654977 A1Applicant: CAN FITE BIOPHARMA LTDPriority: 2023
EP
US
WO
3 publications
PROCESS FOR PREPARING NAMODENOSON
US 20250368676 A1Applicant: CAN FITE BIOPHARMA LTDPriority: 2024
US
WO
2 publications
A3 adenosine receptors for treating diseases associated with OCRL gene dysfunction
CN 121666237 AApplicant: FOND TELETHONPriority: 2023
CN